☰

Yong-Rak Kim - Publications

Affiliations: 
Engineering Mechanics The University of Nebraska - Lincoln, Lincoln, NE 
Area:
Materials Science Engineering, Civil Engineering
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Lee SH, Tonello R, Im ST, Jeon H, Park J, Ford Z, Davidson S, Kim YH, Park CK, Berta T. Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis. Theranostics. 10: 12111-12126. PMID 33204332 DOI: 10.7150/thno.52135  0.309
2020 Kim GC, Lee CG, Verma R, Rudra D, Kim T, Kang K, Nam JH, Kim Y, Im SH, Kwon HK. ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes. Frontiers in Oncology. 10: 642. PMID 32477936 DOI: 10.3389/Fonc.2020.00642  0.334
2020 Kim JW, Min A, Im SA, Jang H, Kim YJ, Kim HJ, Lee KH, Kim TY, Lee KW, Oh DY, Kim JH, Bang YJ. TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy. Cancers. 12. PMID 32028591 DOI: 10.3390/cancers12020334  0.31
2019 Jung JW, Lee JS, Kim J, Im SP, Kim SW, Lazarte JMS, Kim YR, Chun JH, Ha MW, Kim HS, Thompson KD, Jung TS. Characterization of Hagfish () Variable Lymphocyte Receptor-Based Antibody and Its Potential Role in the Neutralization of Nervous Necrosis Virus. Journal of Immunology (Baltimore, Md. : 1950). PMID 31836656 DOI: 10.4049/jimmunol.1900675  0.312
2019 Sim SH, Park IH, Jung KH, Kim SB, Ahn JH, Lee KH, Im SA, Im YH, Park YH, Sohn J, Kim YJ, Lee S, Kim HJ, Chae YS, Park KH, et al. Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16). British Journal of Cancer. PMID 31690831 DOI: 10.1038/s41416-019-0618-z  0.319
2019 Kim JS, Kim K, Jung W, Shin KH, Im SA, Kim HJ, Kim YB, Chang JS, Choi DH, Park YH, Kim DY, Kim TH, Choi BO, Lee SW, Kim S, et al. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12). Breast (Edinburgh, Scotland). 49: 41-47. PMID 31677532 DOI: 10.1016/j.breast.2019.10.007  0.301
2018 Im S, Lee J, Park D, Park A, Kim YM, Kim WJ. Hypoxia-Triggered Transforming Immunomodulator for Cancer Immunotherapy via Photodynamically Enhanced Antigen Presentation of Dendritic Cell. Acs Nano. PMID 30563320 DOI: 10.1021/acsnano.8b07045  0.302
2018 Kim GC, Kwon HK, Lee CG, Verma R, Rudra D, Kim T, Kang K, Nam JH, Kim Y, Im SH. Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness. Oncogenesis. 7: 91. PMID 30467308 DOI: 10.1038/s41389-018-0101-3  0.322
2018 Min A, Eun Kim J, Kim YJ, Min Lim J, Kim S, Won Kim J, Lee KH, Kim TY, Oh DY, Bang YJ, Im SA. Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells. Cancer Letters. PMID 29729292 DOI: 10.1016/j.canlet.2018.04.037  0.317
2018 Lee SH, Lee B, Shim JH, Lee KW, Yun JW, Kim SY, Kim TY, Kim YH, Ko YH, Chung HC, Yu CS, Lee J, Rha SY, Kim TW, Jung KH, et al. Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 29690749 DOI: 10.4143/crt.2018.132  0.308
2018 Lee JS, Kim J, Im SP, Kim SW, Lazarte JMS, Jung JW, Gong TW, Kim YR, Lee JH, Kim HJ, Jung TS. Generation and characterization of hagfish variable lymphocyte receptor B against glycoprotein of viral hemorrhagic septicemia virus (VHSV). Molecular Immunology. 99: 30-38. PMID 29679865 DOI: 10.1016/j.molimm.2018.04.006  0.309
2018 Bang S, Yoo J, Gong X, Liu D, Han Q, Luo X, Chang W, Chen G, Im ST, Kim YH, Strong JA, Zhang MZ, Zhang JM, Lee SY, Ji RR. Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies. Neuroscience Bulletin. PMID 29333591 DOI: 10.1007/S12264-018-0203-0  0.302
2017 Park JH, Choi IS, Kim KH, Kim JS, Lee KH, Kim TY, Im SA, Kim SH, Kim YJ, Kim JH. Treatment Patterns and Outcomes in Elderly Patients with Metastatic Breast Cancer: A Multicenter Retrospective Study. Journal of Breast Cancer. 20: 368-377. PMID 29285042 DOI: 10.4048/jbc.2017.20.4.368  0.311
2017 Park S, Lee S, Lee CG, Park GY, Hong H, Lee JS, Kim YM, Lee SB, Hwang D, Choi YS, Fryer JD, Im SH, Lee SW, Lee Y. Capicua deficiency induces autoimmunity and promotes follicular helper T cell differentiation via derepression of ETV5. Nature Communications. 8: 16037. PMID 28855737 DOI: 10.1038/Ncomms16037  0.302
2017 Jung JW, Lee JS, Kim YR, Im SP, Kim SW, Lazarte JMS, Kim J, Thompson KD, Suh JP, Jung TS. Development of a monoclonal antibody against the CD3ε of olive flounder (Paralichthys olivaceus) and its application in evaluating immune response related to CD3ε. Fish & Shellfish Immunology. PMID 28433716 DOI: 10.1016/j.fsi.2017.04.016  0.308
2017 Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ. CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28111425 DOI: 10.4143/crt.2016.326  0.314
2017 You T, Im S, Kim Y, Little DN. Mechanistic modeling to evaluate structural performance of bituminous pavements with inelastic deformation and fatigue damage of mixtures Journal of Engineering Mechanics-Asce. 143: 4016126. DOI: 10.1061/(Asce)Em.1943-7889.0001197  0.364
2016 Lee SW, Kim YJ, Shin KH, Kim K, Chie EK, Han W, Im SA, Jung SY, Lee KS, Lee ES. A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer. Medicine. 95: e3320. PMID 27175630 DOI: 10.1097/MD.0000000000003320  0.309
2015 Ban H, Im S, Kim YR. Mixed-mode fracture characterization of fine aggregate mixtures using semicircular bend fracture test and extended finite element modeling Construction and Building Materials. 101: 721-729. DOI: 10.1016/J.Conbuildmat.2015.10.083  0.357
2014 Im S, Ban H, Kim Y. Mode-Dependent Fracture Behavior of Asphalt Mixtures with Semicircular Bend Test: Transportation Research Record. 2447: 23-31. DOI: 10.3141/2447-03  0.357
2011 Kwon JH, Chie EK, Kim JH, Im S, Oh D, Kim Y, Han S, Lee K, Jang J, Kim T, Kim JS, Han HS, Kim S, Yoon YB, Bang Y, et al. Phase II trial of postoperative adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiation with gemcitabine in patients with resected pancreatic cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4094. PMID 28020442 DOI: 10.1200/jco.2011.29.15_suppl.4094  0.304
2009 Park J, Han S, Oh D, Kim J, Lee H, Kim Y, Im S, Kim T, Bang Y. Trastuzumab-mediated cardiac dysfunction (CDx) outside of clinical trials: Single Asian center experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e20732. PMID 27962009 DOI: 10.1200/jco.2009.27.15_suppl.e20732  0.308
2008 Lee K, Kim H, Kim Y, Oh D, Kim J, Im S, Kim T, Lee J, Bang Y. Chemotherapy-induced transient CEA and CA19-9 surges in patients with metastatic or recurrent gastric cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 15603. PMID 27947445 DOI: 10.1200/jco.2008.26.15_suppl.15603  0.315
2008 Lee K, Kim M, Kim Y, Ryoo B, Lim H, Song H, Kim H, Lee M, Im S, Chang H, Cho J. Gemcitabine and oxaliplatin combination as the first-line treatment in advanced pancreatic cancer: A multicenter phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 15618. PMID 27947430 DOI: 10.1200/Jco.2008.26.15_Suppl.15618  0.305
2005 Oh DY, Kim YJ, Han SW, Choi IS, Kim JH, Kim DW, Im SA, Kim TY, Heo DS, Bang YJ, Kim NK. Efficacy of reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer (CRC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3720. PMID 27945568 DOI: 10.1200/jco.2005.23.16_suppl.3720  0.303
Show low-probability matches.